Global CV disease Taskforce aims to reduce burden of CV disease by 25% in 2025
The Global Cardiovascular (CV) Disease Taskforce — representing the American College of Cardiology (ACC), World Heart Federation (WHF), American Heart Association (AHA), European Heart Network, European Society of Cardiology (ESC), and other global CV Disease experts, has released a Statement that calls for the implementation of plans to help meet the global target of reducing premature non-communicable disease (NCD) mortality with 25 percent by 2025.
The statement coincides with the two-year anniversary of the first United Nation’s (UN) meeting on NCDs. Following the initial UN declaration in 2011, the NCD Alliance lobbied for the establishment of a concrete goal addressing the worldwide NCD pandemic. Last year, at the one-year anniversary of the UN Summit, an official statement was published by the ACC, the WHF, ESC and the AHA, urging concrete targets to curb preventable death from CV diseases. Two months after this call to action, targets were agreed upon under the NCD Alliance’s guidance.
The Statement aims to call upon the global community to not only endorse the ’25by25’ target, but to ensure that health care professionals work together with governments to make plans that help us meet this target, which should ultimately improve global health.
It is suggested by the authors ‘that the CV disease civil society community of heart and stroke foundations and societies across the globe must have a leading role in the implementation of national NCD plans and ensure a focus on CV disease primordial, primary and secondary prevention and rehabilitation. Sharing best practices, aligning measurements, fostering experience, advancing implementation strategies and providing leadership are critical and feasible measures to ensure that we achieve the ‘25by25’, not only for NCDs but also for CV disease.’
Members of the Global CV Disease Taskforce are developing and will publish concrete metrics around the ‘25by25’ target that are specific to CV disease, and tailored by geographical region by 2014. They have also committed to shaping and supporting the inclusion of CV disease language in national plans. Furthermore, they aim to coordinate and align efforts around implementation of the CV disease-related targets under the ‘25by25’ global target, with a particular focus on reducing tobacco use and hypertension and improving secondary prevention and rehabilitation of CV disease.
The current statement adopts the ‘25by25’ target and 8 additional targets addressing modifiable risk factors and committing to the use of essential medicines, technologies, and drug therapies to prevent heart attacks and strokes. All of this is part of a global monitoring framework and included in the World Health Organisation’s Global Action Plan for the Prevention and Control of NCDs.
Find the Statement online
Smith SC, Chen D, Collins A et al. Moving From Political Declaration to Action on Reducing the Global Burden of Cardiovascular Diseases: A Statement From the Global Cardiovascular Disease Taskforce. J Am Coll Cardiol. 2013: doi:10.1016/j.jacc.2013.08.722